Latest Breaking News On - Therapeutics team - Page 1 : comparemela.com

$25 Million Gift to Penn Medicine and Children's Hospital of Philadelphia Establishes Center for Epilepsy and Neurodevelopmental Disorders

/PRNewswire/ A $25 million gift from an anonymous donor to Penn Medicine and Children s Hospital of Philadelphia (CHOP) will establish the Center for.

$25M Gift Establishes Center for Epilepsy & Neurodevelopmental

Nuvectis Pharma Announces Positive Data for NXP900 in a Preclinical Model of Group 4 Medulloblastoma, A Type of Brain Cancer That Affects Predominantly Pediatric Patients

13.06.2022 - FORT LEE, N.J., June 13, 2022 (GLOBE NEWSWIRE) - Nuvectis Pharma, Inc. (“Nuvectis”, “Company”), a biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need . Seite 1

Aristea is Rehoming Proven Molecules for Rare Inflammatory Diseases

The San Diego-based immunology company is locating and developing molecules where the mechanism of action has either been proven or makes sense.